New evidence supports the use of alternative dosing formulations, expanding TCV delivery options in public health programs     June 14, 2022 – SEOUL, Republic of Korea – A new study jointly conducted by the International Vaccine Institute (IVI) and collaborators shows multidose and single-dose […]